Our Services

Select Therapeutic Competencies

CMC can make or break a CGT approval, as DHC’s experts know well. Time spent on getting CMC development right will nearly always pay dividends by streamlining next steps towards regulatory approval and commercialization.

Visit this domain
CMC

Dark Horse is uniquely positioned to provide both strategic and tactical regulatory assistance to our clients for their global regulatory needs. We are connected with current and former staffers of multiple worldwide regulatory bodies and have supported filings for clients across a wide range of global jurisdictions and stages of development.

Visit this domain
Regulatory

Join our mailing list here.

Dark Horse Consulting and BioTechLogic now share a mailing list.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Text Link
No Stage
Text Link
Commercial
Text Link
Pivotal Clinical
Text Link
Early Clinical
Text Link
R&D / Nonclinical
Text Link
Academic
Text Link
Investor
Text Link
Tools, Tech, and Services
Text Link
Therapeutics
Text Link
Blood-based products
Text Link
Vaccines
Text Link
Oligonucleotides and peptides
Text Link
Complex antibodies
Text Link
Recombinant proteins
Text Link
Biosimilars
Text Link
Combination products
Text Link
Cell therapies
Text Link
Gene therapies